Levoxadrol, with the CAS number 4792-18-1, is a chemical compound that belongs to the class of synthetic drugs. It is primarily recognized for its pharmacological properties, particularly in the context of its use as an antidepressant and anxiolytic agent. The compound exhibits a chiral structure, with its levorotatory form being biologically active. Levoxadrol interacts with various neurotransmitter systems, including serotonin and norepinephrine, which contributes to its therapeutic effects. In terms of physical characteristics, it is typically presented as a white to off-white crystalline powder, which is soluble in organic solvents but may have limited solubility in water. The compound's stability, reactivity, and safety profile are essential considerations in its application, particularly in pharmaceutical formulations. As with many synthetic drugs, understanding its mechanism of action, potential side effects, and interactions with other medications is crucial for its effective and safe use in clinical settings.

levoxadrol

4792-18-1: Levoxadrol, with the CAS number 4792-18-1, is a chemical compound that belongs to the class of synthetic drugs. It is primarily recognized for its pharmacological properties, particularly in the context of its use as an antidepressant and anxiolytic agent. The compound exhibits a chiral structure, with its levorotatory form being biologically active. Levoxadrol interacts with various neurotransmitter systems, including serotonin and norepinephrine, which contributes to its therapeutic effects. In terms of physical characteristics, it is typically presented as a white to off-white crystalline powder, which is soluble in organic solvents but may have limited solubility in water. The compound's stability, reactivity, and safety profile are essential considerations in its application, particularly in pharmaceutical formulations. As with many synthetic drugs, understanding its mechanism of action, potential side effects, and interactions with other medications is crucial for its effective and safe use in clinical settings.

<p>(S,R,R)-2-(2,2-Diphenyl-[1,3]dioxolan-4-yl)-piperidine is a peptide that can be used as a research tool. It has been shown to activate the potassium channel Kv1.1 and inhibit the calcium channel Cav1.1 in rat and guinea pig neurons. It also inhibits the activity of acetylcholine esterase and protein kinase C in rat brain tissue. (S,R,R)-2-(2,2-Diphenyl-[1,3]dioxolan-4-yl)-piperidine binds to the antibody IgG with high affinity and specificity. The binding is reversible and competitively inhibited by an excess of free ligand. This peptide has potential for use as a pharmaceutical agent for treating autoimmune diseases such as multiple sclerosis or rheumatoid arthritis.</p>

CAS 4792-18-1

levoxadrol

(S,R,R)-2-(2,2-Diphenyl-[1,3]dioxolan-4-yl)-piperidine

Ref: 3D-EAA79218